A study finds that many patients with severe alopecia areata achieve meaningful hair regrowth after switching JAK inhibitors, ...

A centuries-old Chinese medicinal root is getting new scientific attention as a potential game-changer for common hair loss.

For decades, the fight against baldness has been framed as a choice between harsh pharmaceuticals and cosmetic cover ups. Now ...

Postpartum hair loss can feel alarming, learn what the evidence says about when shedding peaks, what may prolong it, and when ...

Studies evaluating the oral JAK inhibitor in adults and adolescents with non-segmental vitiligo are submitted for approval of the expanded indication.

Hyperkalemia More Common in Older Women on Spironolactone Hyperkalemia was more common among older women treated with spironolactone for a skin condition, and among those with comorbidities, but cases ...

US Vet Study Identifies Risk Factors for Acral Melanoma A study identified risk factors for acral melanoma in US veterans, including Agent Orange exposure.

New Cellular Clues Reveal a Path to Preventing Sarcopenia Companion studies suggest muscle begins to decline decades before sarcopenia takes hold for keeps. The best part: The process could ...

ICI Use and Secondary Cancer Risk: Is There a Link? A recent analysis attempts to clarify whether the growing use of immune checkpoint inhibitors to treat metastatic cancer was associated with an ...

Help us make Medscape the best clinical resource possible. Please use this form to submit your questions or comments on how to make this resource center more useful to clinicians.

Problems with the PREVENT score, a breakthrough in lipid-lowering therapy, a surprising benefit in stroke care, and more thoughts on statins and preventive care of heart disease are the topics John ...

Today on Medscape : Get the latest medical news, clinical trial coverage, drug updates, journal articles, CME activities & more on Medscape. A free resource for physicians.